Attitudes toward predeployment and experimental vaccinations among troops deployed to Operation Iraqi Freedom and Operation Enduring Freedom

Journal of Travel Medicine

Volumn 15, Issue 2, 2008, Pages 68-76

  Riddle, Mark S ^a,e   Patel, Shimul S ^b   Sanders, John W ^c   Armstrong, Adam W ^a   Putnam, Shannon D ^d   Schlett, Carey D ^a   Tribble, David R ^e  

^a US Naval Medical Research Unit No 3 Egypt   (Egypt)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^e NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIR FORCE; ARMY; ARTICLE; ATTITUDE TO HEALTH; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; FEMALE; FREEDOM; HEALTH SURVEY; HUMAN; IRAQ; MALE; SEX DIFFERENCE; SOLDIER; VACCINATION;

ADULT; ATTITUDE TO HEALTH; BACTERIAL VACCINES; COMMUNICABLE DISEASE CONTROL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IRAQ; MALE; MILITARY PERSONNEL; QUESTIONNAIRES; SELF CARE; UNITED STATES; VACCINATION; VIRAL VACCINES; WAR;

EID: 40849126862     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2007.00173.x     Document Type: Article

References (43)

1. Zapor MJ, Moran KA. Infectious diseases during wartime. Curr Opin Infect Dis 2005 18 : 395 399.
2. Hyams KC, Bourgeois AL, Merrell BR, et al. Diarrheal disease during Operation Desert Shield. N Engl J Med 1991 325 : 1423 1428.
3. Sanders JW. Azithromycin and loperamide is comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in U.S. military personnel in Turkey. San Francisco : Infectious Disease Society of America, 2005.
4. Takafuji ET, Russell PK. Military immunizations. Past, present, and future prospects. Infect Dis Clin North Am 1990 4 : 143 158.
5. Lemon SM, Thaul S, Fisseha S, O'Maonaigh HC. Protecting our forces: improving vaccine acquisition and availability in the U.S. military. Washington, DC : Institute of Medicine of the National Academies, 2003.
6. Mahan CM, Kang HK, Dalager NA, Heller JM. Anthrax vaccination and self-reported symptoms, functional status, and medical conditions in the National Health Survey of Gulf War Era Veterans and Their Families. Ann Epidemiol 2004 14 : 81 88.
7. Cherry N, Creed F, Silman A, et al. Health and exposures of United Kingdom Gulf war veterans. Part II: the relation of health to exposure. Occup Environ Med 2001 58 : 299 306.
8. Hotopf M, David A, Hull L, et al. Risk factors for continued illness among Gulf War veterans: a cohort study. Psychol Med 2004 34 : 747 754.
9. Wolfe J, Proctor SP, Erickson DJ, Hu H. Risk factors for multisymptom illness in US Army veterans of the Gulf War. J Occup Environ Med 2002 44 : 271 281.
10. Hotopf M, David A, Hull L, et al. Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study. BMJ 2000 320 : 1363 1367.
11. Schumm WR, Reppert EJ, Jurich AP, et al. Self-reported changes in subjective health and anthrax vaccination as reported by over 900 Persian Gulf War era veterans. Psychol Rep 2002 90 : 639 653.
12. Murphy D, Dandeker C, Horn O, et al. UK armed forces responses to an informed consent policy for anthrax vaccination: a paradoxical effect? Vaccine 2006 24 : 3109 3114.
13. Bolton JP, Lee HA, Gabriel R. Vaccinations as risk factors for ill health in veterans of the Gulf war. Conclusion may be flawed by inadequate data. BMJ 2001 322 : 361 362.
14. Russell KL, Hawksworth AW, Ryan MA, et al. Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004. Vaccine 2006 24 : 2835 2842.
15. Artenstein AW, Opal JM, Opal SM, et al. History of U.S. military contributions to the study of vaccines against infectious diseases. Mil Med 2005 170 : 3 11.
16. Putnam SD, Sanders JW, Frenck RW, et al. Self-reported description of diarrhea among military populations in operations Iraqi Freedom and Enduring Freedom. J Travel Med 2006 13 : 92 99.
17. Sanders JW, Putnam SD, Riddle MS, Tribble DR. Military importance of diarrhea: lessons from the Middle East. Curr Opin Gastroenterol 2005 21 : 9 14.
18. Sanders JW, Putnam SD, Frankart C, et al. Impact of illness and non-combat injury during Operations Iraqi Freedom and Enduring Freedom (Afghanistan). Am J Trop Med Hyg 2005 73 : 713 719.
19. Sanders JW, Putnam SD, Riddle MS, et al. The epidemiology of self-reported diarrhea in operations Iraqi freedom and enduring freedom. Diagn Microbiol Infect Dis 2004 50 : 89 93.
20. Newman PA, Duan N, Roberts KJ, et al. HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment. J Acquir Immune Defic Syndr 2006 41 : 210 217.
21. Carter LB. Iraq summary of US Forces. CRS report for congress. Library of Congress, 2005. Report No.: RL31763. Available at : http://www.fas.org/sgp/crs/ mideast/RL31763.pdf Accessed 2007 Nov 28)
22. Segal DR, Segal MW. America's military population. Popul Bull 2004 59 : 19 25.
23. Hochbaum GM. Why people seek diagnostic x-rays. Public Health Rep 1956 71 : 377 380.
24. Finfgeld DL, Wongvatunyu S, Conn VS, et al. Health belief model and reversal theory: a comparative analysis. J Adv Nurs 2003 43 : 288 297.
25. Crockett M, Keystone J. "I hate needles" and other factors impacting on travel vaccine uptake. J Travel Med 2005 12 (Suppl 1 S41 S46.
26. Tarman GJ, Kane CJ, Moul JW, et al. Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology 2000 56 : 1016 1020.
27. Paris RM, Bedno SA, Krauss MR, et al. Weighing in on type 2 diabetes in the military: characteristics of U.S. military personnel at entry who develop type 2 diabetes. Diabetes Care 2001 24 : 1894 1898.
28. Clark JY, Thompson IM. Military rank as a measure of socioeconomic status and survival from prostate cancer. South Med J 1994 87 : 1141 1144.
29. Johnson IS, Milner PC. Is the Jarman score better than social class at assessing the need for prevention and primary care? Fam Pract 1988 5 : 105 110.
30. Atkins CJ, Senn K, Rupp J, et al. Attendance at health promotion programs: baseline predictors and program outcomes. Health Educ Q 1990 17 : 417 428.
31. Williams IT, Milton JD, Farrell JB, Graham NM. Interaction of socioeconomic status and provider practices as predictors of immunization coverage in Virginia children. Pediatrics 1995 96 : 439 446.
32. Marks JS, Halpin TJ, Irvin JJ, et al. Risk factors associated with failure to receive vaccinations. Pediatrics 1979 64 : 304 309.
33. Mastroianni GR. Occupations, cultures, and leadership in the Army and Airforce. Parameters 2005 2006 : 76 90.
34. Yazbak FE, Yazbak K. Live virus vaccination near a pregnancy: flawed policies, tragic results. Med Hypotheses 2002 59 : 283 288.
35. Pittman PR, Kim-Ahn G, Pifat DY, et al. Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans. Vaccine 2002 20 : 1412 1420.
36. Sumilo D, Stewart-Brown S. The causes and consequences of injury in students at UK institutes of higher education. Public Health 2006 120 : 125 131.
37. Weden MM, Zabin LS. Gender and ethnic differences in the co-occurrence of adolescent risk behaviors. Ethn Health 2005 10 : 213 234.
38. McManus J, Mehta SG, McClinton AR, et al. Informed consent and ethical issues in military medical research. Acad Emerg Med 2005 12 : 1120 1126.
39. Faden RR, Taylor HA, Seiler NK. Consent and compensation: a social compact for smallpox vaccine policy in the event of an attack. Clin Infect Dis 2003 36 : 1547 1551.
40. Staudenmeier JJ, Bacon BL, Ruiz RT, Diebold CJ. Anthrax refusers: a 2nd infantry division perspective. Mil Med 2003 168 : 520 522.
41. Friedlander AM, Pittman PR, Parker GW. Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. JAMA 1999 282 : 2104 2106.
42. Wittek R. Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy. Int J Infect Dis 2006 10 : 193 201.
43. GAO. Force health protection and surveillance policy compliance was mixed, but appears better for recent deployments. Washington, DC : GAO-05-120, 2004. Available at : http://www.gao.gov/new.items/d05120.pdf Accessed 2007 Nov 28)